230 related articles for article (PubMed ID: 29027206)
1. Low-grade gastrointestinal lymphoma in dogs: 20 cases (2010 to 2016).
Lane J; Price J; Moore A; Dandrieux JRS; Clifford C; Curran K; Choy K; Cannon C
J Small Anim Pract; 2018 Mar; 59(3):147-153. PubMed ID: 29027206
[TBL] [Abstract][Full Text] [Related]
2. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
3. Characterization of lymphocytes in canine gastrointestinal lymphoma.
Coyle KA; Steinberg H
Vet Pathol; 2004 Mar; 41(2):141-6. PubMed ID: 15017027
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience.
Smallwood K; Tanis JB; Grant IA; Blackwood L; Killick DR; Amores-Fuster I; Elliott J; Mas A; Harper A; Marrington M; Finotello R
Vet Comp Oncol; 2019 Jun; 17(2):165-173. PubMed ID: 30666777
[TBL] [Abstract][Full Text] [Related]
5. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs.
Berger EP; Johannes CM; Jergens AE; Allenspach K; Powers BE; Du Y; Mochel JP; Fox LE; Musser ML
J Vet Intern Med; 2018 Nov; 32(6):2045-2053. PubMed ID: 30307656
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of 30 cases (1997-2004) of canine gastrointestinal lymphoma.
Frank JD; Reimer SB; Kass PH; Kiupel M
J Am Anim Hosp Assoc; 2007; 43(6):313-21. PubMed ID: 17975213
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of intraocular lymphosarcoma in a dog by use of a polymerase chain reaction assay for antigen receptor rearrangement.
Pate DO; Gilger BC; Suter SE; Clode AB
J Am Vet Med Assoc; 2011 Mar; 238(5):625-30. PubMed ID: 21355805
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.
Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB
J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
[TBL] [Abstract][Full Text] [Related]
10. Concurrent with T-zone lymphoma and high-grade gastrointestinal cytotoxic T-cell lymphoma in a dog.
Suwa A; Shimoda T
J Vet Med Sci; 2017 Apr; 79(4):736-739. PubMed ID: 28302939
[TBL] [Abstract][Full Text] [Related]
11. Rectal lymphoma in 11 dogs: a retrospective study.
Van den Steen N; Berlato D; Polton G; Dobson J; Stewart J; Maglennon G; Hayes AM; Murphy S
J Small Anim Pract; 2012 Oct; 53(10):586-91. PubMed ID: 22882127
[TBL] [Abstract][Full Text] [Related]
12. Treatment of canine non-indolent T cell lymphoma using the VELCAP-TSC protocol: A retrospective evaluation of 70 dogs (2003-2013).
Goodman IH; Moore AS; Frimberger AE
Vet J; 2016 May; 211():39-44. PubMed ID: 27017053
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic evaluation and treatment recommendations for dogs with substage-a high-grade multicentric lymphoma: results of a survey of veterinarians.
Regan RC; Kaplan MS; Bailey DB
Vet Comp Oncol; 2013 Dec; 11(4):287-95. PubMed ID: 22380460
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
Curran K; Thamm DH
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():147-55. PubMed ID: 26279153
[TBL] [Abstract][Full Text] [Related]
15. Association between lymphocyte antigen receptor gene rearrangements and histopathological evaluation in canine chronic enteropathy.
Hiyoshi S; Ohno K; Uchida K; Goto-Koshino Y; Nakashima K; Fukushima K; Kanemoto H; Maeda S; Tsujimoto H
Vet Immunol Immunopathol; 2015 Jun; 165(3-4):138-44. PubMed ID: 25912485
[TBL] [Abstract][Full Text] [Related]
16. Asparaginase and MOPP treatment of dogs with lymphoma.
Brodsky EM; Maudlin GN; Lachowicz JL; Post GS
J Vet Intern Med; 2009; 23(3):578-84. PubMed ID: 19645842
[TBL] [Abstract][Full Text] [Related]
17. Geographical differences in survival of dogs with non-Hodgkin lymphoma treated with a CHOP based chemotherapy protocol.
Wilson-Robles H; Budke CM; Miller T; Dervisis N; Novosad A; Wright Z; Thamm DH; Vickery K; Burgess K; Childress M; Lori J; Saba C; Rau S; Silver M; Post G; Reeds K; Gillings S; Schleis S; Stein T; Brugmann B; DeRegis C; Smrkovski O; Lawrence J; Laver T
Vet Comp Oncol; 2017 Dec; 15(4):1564-1571. PubMed ID: 28419683
[TBL] [Abstract][Full Text] [Related]
18. Sonographic features of gastrointestinal lymphoma in 15 dogs.
Frances M; Lane AE; Lenard ZM
J Small Anim Pract; 2013 Sep; 54(9):468-74. PubMed ID: 23888986
[TBL] [Abstract][Full Text] [Related]
19. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and adverse events of continuous l-asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin.
Nakagawa T; Kojima M; Ohno K; Chambers JK; Uchida K; Ohmi A; Goto-Koshino Y; Tomiyasu H; Tsujimoto H
Vet Comp Oncol; 2022 Mar; 20(1):102-108. PubMed ID: 34213084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
